-
Jan 14, 2025 | 
drugdiscoveryonline.com | Aashna Goyal |Guriqbal Singh |Christopher C. Conway |Deanna Mudie Ph.D
2025 BioPlan's 22nd Annual Survey--Biopharmaceutical ManufacturingFor over 20 years, we continue to be the leader in providing the biopharma industry's most comprehensive benchmarking analysis. We invite you to participate in our 22nd Annual Survey in Biopharmaceutical Manufacturing! For all completed, qualified responses, we'll send an Amazon egift card, a copy of the summary results (mid-2025), and our 2025 Top Trends in Biomanufacturing White Paper.
-
Nov 27, 2024 | 
clinicalleader.com | Guriqbal Singh |Aashna Goyal
By Aashna Goyal and Guriqbal Singh, RegWeb Consulting Services Inc., Canada
Pharmacovigilance plays a crucial role in ensuring the safety and efficacy of pharmaceutical products by detecting, assessing, and preventing adverse drug reactions (ADRs). Clinical research has long been the backbone of medical advancements, providing the necessary evidence to approve new therapies and improve existing ones. Both fields are data-intensive, requiring high accuracy and robust methodologies.
-
Sep 4, 2024 | 
clinicalleader.com | Guriqbal Singh |Kamil Shaik
Webinar: Making an Impact on Sustainability Through Vendor Collaboration and Smart Procurement StrategiesWith reports that industries worldwide could save $437 billion per year by 2030 by improving energy efficiency alone, sustainability initiatives are a driving force behind the evolution of business processes and technological development.
-
Jul 17, 2024 | 
clinicalleader.com | Guriqbal Singh |Kamil Shaik
By Guriqbal Singh and Kamil Shaik, RegWeb Consulting Services Inc.
In the rapidly evolving healthcare sector, where advancements have the potential to revolutionize lives and our comprehension of medicine, the EU has made a significant stride by implementing the Clinical Trial Regulation (EU) 536/2014 (CT Regulation), which replaces the old Clinical Trials Directive 2001/20/EC (CT Directive).
-
Apr 1, 2024 | 
outsourcedpharma.com | Kamil Shaik |Guriqbal Singh |Jean-Sebastien Steffen |Ann McMahon |Louis Garguilo
Webinar: De-Risking The Aseptic Drug-Filling Process And Optimizing ProductionIn the aseptic drug-filling process for biotherapeutics, your company may find it challenging to meet regulatory compliance standards, putting the safety and effectiveness of your products at risk. Join us and gain valuable insights into enhancing the efficiency and reliability of the drug product manufacturing process.
-
Mar 15, 2024 | 
pharmaceuticalonline.com | Kamil Shaik |Guriqbal Singh |Kurt McCauley
Drug developers aspire to treat patients globally, but navigating diverse regulatory structures around the world gets tricky. These consultants offer a primer on the regulatory bodies of the world. Quality Control In Medical Writing: What It Means And Why It MattersIn effective organizations completing projects smoothly, learn why quality control is not an “I email you a document and you review it” task meant to be completed quickly.
-
Mar 14, 2024 | 
biosimilardevelopment.com | Erich Bozenhardt |Kamil Shaik |Guriqbal Singh
Get more biosimilar development insight with our FREE newsletter
Newsletter
| March 14, 2024
After decades of helping to rescue biotech and pharma companies from environmental monitoring excursions, Herman and Erich Bozenhardt bring this discussion about specific problems you should avoid. A key challenge to better uptake of continuous processes in biologics manufacturing is the necessity to link unit operations.
-
Mar 13, 2024 | 
advancingrna.com | Kamil Shaik |Guriqbal Singh |A. J. Goldman |K. Flook
Hosted by Advancing RNA's Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. Here, in Episode 3, Welch explores the similarities that exist between the art of crafting a high-quality violin and the upstream process development work mRNA therapeutics experts are performing today to create the most ideal mRNA drug substance.
-
Feb 21, 2024 | 
bioprocessonline.com | Kamil Shaik |Guriqbal Singh
Get more Bioprocess insight with our FREE newsletter
Guest Column
| February 21, 2024
By Kamil Shaik and Guriqbal Singh, RegWeb
Regulatory environments comprise a wide range of regulations, laws, and standards enacted by governments and their agencies to regulate the conduct of pharmaceutical businesses and individuals.
-
Feb 21, 2024 | 
lifescienceleader.com | Kamil Shaik |Guriqbal Singh
Get more Life Science Leader insight with our FREE newsletter.
Guest Column
| February 21, 2024
By Kamil Shaik and Guriqbal Singh, RegWeb
Regulatory environments comprise a wide range of regulations, laws, and standards enacted by governments and their agencies to regulate the conduct of pharmaceutical businesses and individuals.
